Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT06929559

Muscular Synergies and Behavioral Adaptations of Gait in Pain Anticipation (SYAMAPP)

Conditions: Nocebo Effect, Pain Anticipation

Sex: All
Ages: 18 Years – 35 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 34
Sponsor: Universite de Picardie Jules Verne

Location: Université de Picardie Jules Verne Amiens

Summary

The purpose of this study is to determine whether the anticipation of pain influences gait control and psychophysiological responses in healthy individuals. Participants will receive a neutral cream described either as potentially painful (experimental group) or inert (control group), and their behavioral and physiological adaptations will be measured during walking tasks.

Eligibility Criteria

Inclusion Criteria: * Aged 18-35 years * Healthy participant with no self-reported diagnosed neurological, musculoskeletal, or cardiovascular disorders * Body Mass Index (BMI) \< 30 * Ability to walk unaided for at least 10 minutes without major physical limitations Exclusion Criteria: * Presence of pain at the time of testing * Self-reported diagnosed condition affecting mobility * Known allergy to any component of the study cream * Allergy to EMG electrode adhesives * Inability to stand unassisted for more than 1 minute * Inability to walk/run at the required speed and distance * Weight exceeding 150 kg (due to treadmill limitations) * Recent intake of: * Analgesics (within 6 hours) * Cigarettes (within 6 hours) * Caffeine (within 2 hours) * Skin lesions at the cream application site * Pregnancy * Failure to understand instructions * Daytime pain reported by participant on day of experimentation

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06929559). StuddyBuddy aggregates publicly available trial information.